News uniQure craters on Huntington’s gene therapy data uniQure has presented new results from its phase 1/2 study of its gene therapy for Huntington’s disease that
News BMS upgrades Evotec neurology alliance, now worth up to $4bn Bristol-Myers Squibb has expanded a long-running alliance with Evotec once again, paying another $50 million upfront to deepen their collaboration on drugs to treat neurod
Events Partner Content Protein Misfolding Drug Discovery Summit Discover & Translate Disease-Modifying Therapeutics
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
